ISSN: 1548-3576

Journal Guideline

Current HIV/AIDS Reports Q1 Unclaimed

Current Science, Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current HIV/AIDS Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of conditions associated with HIV/AIDS. Presents the views of experts on current advances in HIV/AIDS in a clear and readable form Gathers and synthesizes important recent papers on HIV/AIDS Alerts readers to useful web sites on the topic It has an SJR impact factor of 1,658.

Current HIV/AIDS Reports focuses its scope in these topics and keywords: hiv, models, researchthe, prospectshealth, prevent, opioid, obesity, murine, matter, state, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Infectious Diseases (Q1) Virology (Q1)

Price

3060 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,658

SJR Impact factor

72

H Index

43

Total Docs (Last Year)

166

Total Docs (3 years)

3619

Total Refs

785

Total Cites (3 years)

166

Citable Docs (3 years)

3.84

Cites/Doc (2 years)

84.16

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Reviews Microbiology Q1
Clinical Microbiology Reviews Q1
The Lancet Infectious Diseases Q1
Cellular and Molecular Immunology Q1
Drug Resistance Updates Q1

Compare this journals

Aims and Scope

Best articles by citations

Management of patients with the immune reconstitution inflammatory syndrome

Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges

Enhancing the Benefits of Antiretroviral Therapy in Vietnam: Towards Ending AIDS

Interventions to Improve Linkage to HIV Care in the Era of "Treat All" in Sub-Saharan Africa: a Systematic Review

Interventions to Reduce Alcohol Use among HIV-Infected Individuals: A Review and Critique of the Literature

Therapeutic drug monitoring: Pharmacologic considerations for antiretroviral drugs

Neurocognitive Phenotyping of HIV in the Era of Antiretroviral Therapy

HIV-related neurocognitive impairment in the HAART era

HIV-Related Research in Correctional Populations: Now is the Time

Oral HPV complications in HIV-infected patients

Endothelial dysfunction in HIV infection

Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents

SHOW MORE ARTICLES

Using the Pathogenic and Nonpathogenic Nonhuman Primate Model for Studying Non-AIDS Comorbidities

Implementing Community Engagement for Combination Prevention: Lessons Learnt From the First Year of the HPTN 071 (PopART) Community-Randomized Study

The potential of RNA interference-based therapies for viral infections

PrEP Stigma: Implicit and Explicit Drivers of Disparity

Use of Human Mucosal Tissue to Study HIV-1 Pathogenesis and Evaluate HIV-1 Prevention Modalities

Managing HIV peripheral neuropathy

The medical management of opioid dependence in HIV primary care settings

Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings

Evaluating the Clinical Benefit of Interleukin-2 Plus Antiretroviral Therapy: Is Raising CD4+ Cell Counts Sufficient?

Modified directly observed therapy to improve HIV treatment outcomes: Little impact with potent, once-daily therapy in unselected antiretroviral-na?Øve patients

HIV antiretroviral therapy in resource-limited settings: Experiences from Haiti

Hepatitis C virus treatment: The beginning of a new era